0

524703

SANDUPHQ

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

SANDU PHARMACEUTICALS LTD. Share Price Today

Investment Returns

Over 1 Month 6.89% Over 3 Months 23.98% Over 6 Months 6.43% Over 1 Year -18.45%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

SANDU PHARMACEUTICALS LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 39.80
  • P/E Ratio (TTM) 22.99
  • Beta 0.69
  • Book Value / share 36.33
  • Return on equity 4.74%
  • EPS (TTM) 1.83
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.04
info icon alternate text

SANDU PHARMACEUTICALS LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 16.85
Operating Expense 16.48
Net Profit 0.04
Net Profit Margin (%) 0.23
Earnings Per Share (EPS) 0.04
EBITDA 0.94
Effective Tax Rate (%) 93.33
Particulars DEC 2025 (Values in Cr)
Revenue 18.76
Operating Expense 17.92
Net Profit 0.98
Net Profit Margin (%) 5.22
Earnings Per Share (EPS) 1.01
EBITDA 1.06
Effective Tax Rate (%) -13.95
Particulars SEP 2025 (Values in Cr)
Revenue 17.62
Operating Expense 16.96
Net Profit 0.52
Net Profit Margin (%) 2.95
Earnings Per Share (EPS) 0.54
EBITDA 0.91
Effective Tax Rate (%) 26.76
Particulars JUN 2025 (Values in Cr)
Revenue 16.70
Operating Expense 16.38
Net Profit 0.22
Net Profit Margin (%) 1.31
Earnings Per Share (EPS) 0.23
EBITDA 0.55
Effective Tax Rate (%) 35.29
Particulars MAR 2025 (Values in Cr)
Revenue 14.07
Operating Expense 13.79
Net Profit 0.33
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.34
EBITDA 0.52
Effective Tax Rate (%) 5.88
Particulars MAR 2026 (Values in Cr)
Revenue 69.93
Operating Expense 67.72
Net Profit 1.77
Net Profit Margin (%) 2.53
Earnings Per Share (EPS) 1.83
EBITDA 3.45
Effective Tax Rate (%) 33.45
Particulars MAR 2025 (Values in Cr)
Revenue 67.19
Operating Expense 65.19
Net Profit 1.55
Net Profit Margin (%) 2.30
Earnings Per Share (EPS) 1.60
EBITDA 2.93
Effective Tax Rate (%) 28.24
Particulars MAR 2024 (Values in Cr)
Revenue 67.28
Operating Expense 65.63
Net Profit 1.46
Net Profit Margin (%) 2.17
Earnings Per Share (EPS) 1.51
EBITDA 2.71
Effective Tax Rate (%) 29.46
Particulars MAR 2023 (Values in Cr)
Revenue 65.35
Operating Expense 63.46
Net Profit 1.52
Net Profit Margin (%) 2.32
Earnings Per Share (EPS) 1.62
EBITDA 2.82
Effective Tax Rate (%) 31.53
Particulars MAR 2022 (Values in Cr)
Revenue 65.50
Operating Expense 63.26
Net Profit 1.59
Net Profit Margin (%) 2.42
Earnings Per Share (EPS) 1.99
EBITDA 2.96
Effective Tax Rate (%) 31.46
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.63
ROE % 4.74
ROCE % 6.87
Total Debt to Total Equity 0.00
EBITDA Margin 4.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.01
ROE % 4.11
ROCE % 5.98
Total Debt to Total Equity 0.00
EBITDA Margin 4.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.62
ROE % 3.87
ROCE % 5.86
Total Debt to Total Equity 0.00
EBITDA Margin 4.30
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.63
ROE % 4.74
ROCE % 6.87
Total Debt to Total Equity 0.00
EBITDA Margin 4.36
Particulars MAR 2024 (Values in Cr)
Book Value / Share 33.01
ROE % 4.11
ROCE % 5.98
Total Debt to Total Equity 0.00
EBITDA Margin 4.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 40.62
ROE % 4.56
ROCE % 6.89
Total Debt to Total Equity 0.00
EBITDA Margin 4.32
Particulars MAR 2022 (Values in Cr)
Book Value / Share 30.71
ROE % 6.13
ROCE % 9.37
Total Debt to Total Equity 0.00
EBITDA Margin 4.52
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.63
ROE % 4.92
ROCE % 7.85
Total Debt to Total Equity 0.03
EBITDA Margin 4.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 55.71
Total Liabilities 55.71
Total Equity 42.01
Share Outstanding 0
Price to Book Ratio 1.41
Return on Assets (%) 2.78
Return on Capital (%) 3.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.20
Total Assets 52.41
Total Liabilities 52.41
Total Equity 40.59
Share Outstanding 0
Price to Book Ratio 1.74
Return on Assets (%) 2.78
Return on Capital (%) 3.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.29
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 0
Price to Book Ratio 1.29
Return on Assets (%) 2.80
Return on Capital (%) 3.87
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.65
Total Assets 55.71
Total Liabilities 55.71
Total Equity 42.01
Share Outstanding 0
Price to Book Ratio 1.41
Return on Assets (%) 2.77
Return on Capital (%) 3.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 52.41
Total Liabilities 52.41
Total Equity 40.59
Share Outstanding 0
Price to Book Ratio 1.74
Return on Assets (%) 2.78
Return on Capital (%) 3.6
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 54.16
Total Liabilities 54.16
Total Equity 39.24
Share Outstanding 0
Price to Book Ratio 1.29
Return on Assets (%) 2.81
Return on Capital (%) 3.88
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 4.17
Total Assets 49.28
Total Liabilities 49.28
Total Equity 36.47
Share Outstanding 0
Price to Book Ratio 2.29
Return on Assets (%) 3.22
Return on Capital (%) 4.36
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 11.65
Total Assets 46.96
Total Liabilities 46.96
Total Equity 33.49
Share Outstanding 0
Price to Book Ratio 1.08
Return on Assets (%) 2.32
Return on Capital (%) 3.26
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 1.53
Cash from Investing -0.18
Cash from Financing -0.46
Net change in Cash 0.30
Free Cash Flow 2.46
Particulars MAR 2024 (Values in Cr)
Net Income 2.07
Cash from Operations 1.25
Cash from Investing -1.30
Cash from Financing -0.72
Net change in Cash -1.27
Free Cash Flow 2.68
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 0.92
Cash from Investing 0.53
Cash from Financing 0.57
Net change in Cash 1.33
Free Cash Flow 1.98
Particulars MAR 2025 (Values in Cr)
Net Income 2.15
Cash from Operations 1.53
Cash from Investing -0.17
Cash from Financing -0.46
Net change in Cash 0.30
Free Cash Flow 2.47
Particulars MAR 2024 (Values in Cr)
Net Income 2.07
Cash from Operations 1.26
Cash from Investing -1.30
Cash from Financing -0.72
Net change in Cash -1.27
Free Cash Flow 2.68
Particulars MAR 2023 (Values in Cr)
Net Income 2.22
Cash from Operations 0.92
Cash from Investing 0.52
Cash from Financing 0.57
Net change in Cash 1.32
Free Cash Flow 1.98
Particulars MAR 2022 (Values in Cr)
Net Income 2.31
Cash from Operations 1.82
Cash from Investing -5.47
Cash from Financing 0.93
Net change in Cash -3.58
Free Cash Flow 2.66
Particulars MAR 2021 (Values in Cr)
Net Income 1.68
Cash from Operations 8.04
Cash from Investing -5.57
Cash from Financing 1.29
Net change in Cash 3.31
Free Cash Flow 8.17
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 14.15 1.65 262.39 23.12 38.85
BLISS GVS PHARMA LTD 419.15 33.91 3.71 4434.14 118.35 462.70
CIPLA LTD 1388.25 29.46 3.25 112149.13 1165.55 1672.20
FERMENTA BIOTECH LTD. 341.00 15.04 2.46 1003.60 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.24 23.94 4.41 262.39 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 554.85 24.87 4.33 1604.11 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8383.40 109.49 24.01 20958.50 7630.00 10653.05
BLISS GVS PHARMA LTD 419.15 45.07 3.83 4434.14 118.35 462.70

SANDU PHARMACEUTICALS LTD. shareholding pattern

Holding
62.2%
37.78%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

SANDU PHARMACEUTICALS LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
41.18 -2.11 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 42.40
  • 26 Days 41.20
  • 10 Days 42.20
  • 50 Days 40.00
  • 12 Days 42.10
  • 100 Days 39.30
  • 20 Days 41.60
  • 200 Days 41.10
42.56 PIVOT
First Support 41.12 First Resistance 43.47 Second Support 40.21 Second Resistance 44.91 Third Support 38.77 Third Resistance 45.82
RSI 53.46 ADX 38.47 MACD 0.95 Williams % R -58.08 Commodity Channel Index (CCI) 58.77
Date 2026-06-08 Week 2433.00 Same Day 2141.00 Month 4226.00
1 Year 0.69 3 Year 0.68
Over 1 Month
6.89% down
Over 1 Year
-18.45% down
Over 3 Months
23.98% down
Over 3 Years
-10.12% down
Over 6 Months
6.43% down
Over 5 Years
-3.43% down

SANDU PHARMACEUTICALS LTD. Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
18 Sep 2025 0.8 Final 18 Sep 2025 Equity shares
19 Sep 2024 0.8 Final 20 Sep 2024 Equity shares
18 Sep 2023 0.75 Final 19 Sep 2023 Equity shares
23 Sep 2022 0.75 Final 23 Sep 2022 Equity shares
22 Sep 2021 0.5 Final 24 Sep 2021 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sandu Pharmaceuticals Ltd?

Answer Field

Sandu Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 41.18 as on Jun 10 2026 03:29 PM.

What is the Market Cap of Sandu Pharmaceuticals Ltd Share?

Answer Field

The market cap of Sandu Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 39.80 as on Jun 10 2026 03:29 PM.

What is the 52 Week High and Low of Sandu Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Sandu Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 58.28 and ₹ 30.00.

What is 1 year return for Sandu Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -18.37%.

What is the P/E Ratio of Sandu Pharmaceuticals Ltd Share?

Answer Field

As on Jun 10 2026 03:29 PM the price-to-earnings (PE) ratio for Sandu Pharmaceuticals Ltd share is 22.99.

What is the PB ratio of Sandu Pharmaceuticals Ltd Share?

Answer Field

As on Jun 10 2026 03:29 PM, the price-to-book (PB) ratio for Sandu Pharmaceuticals Ltd share is 36.33.

How to Buy Sandu Pharmaceuticals Ltd Share?

Answer Field

You can trade in Sandu Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sandu Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Sandu Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sandu Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|